These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 15081960)

  • 1. Trends in the development of therapeutic anti-cytokine antibodies.
    Reichert JM
    Drug Discov Today; 2004 Apr; 9(8):348. PubMed ID: 15081960
    [No Abstract]   [Full Text] [Related]  

  • 2. Novel therapeutic targets along the Th17 pathway.
    Ouyang W; Filvaroff E; Hu Y; Grogan J
    Eur J Immunol; 2009 Mar; 39(3):670-5. PubMed ID: 19283720
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Therapeutic prospects in autoimmunity].
    Revillard JP
    Rev Prat; 1994 Jan; 44(1):93-7. PubMed ID: 8178066
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vaccination with cytokines in autoimmune diseases.
    Delavallée L; Assier E; Denys A; Falgarone G; Zagury JF; Muller S; Bessis N; Boissier MC
    Ann Med; 2008; 40(5):343-51. PubMed ID: 18484346
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Update on therapeutic monoclonal antibodies.
    Bussel JB; Giulino L; Lee S; Patel VL; Sandborg C; Stiehm ER
    Curr Probl Pediatr Adolesc Health Care; 2007 Apr; 37(4):118-35. PubMed ID: 17434008
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Setting the cytokine trap for autoimmunity.
    Dinarello CA
    Nat Med; 2003 Jan; 9(1):20-2. PubMed ID: 12514715
    [No Abstract]   [Full Text] [Related]  

  • 7. Autoimmune diseases are connected with disturbances in cytokine synthesis, and therapy with IFN-gamma blockers is their main pathogenetic treatment.
    Skurkovich B; Skurkovich S
    Ann N Y Acad Sci; 2007 Aug; 1109():167-77. PubMed ID: 17785303
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immune therapies of autoimmune diseases: are we approaching a real cure?
    Chatenoud L
    Curr Opin Immunol; 2006 Dec; 18(6):710-7. PubMed ID: 17011768
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Monoclonal antibodies in the immunotherapy of autoimmune diseases.
    Perosa F; Luccarelli G; Prete M; Dammacco F
    Ann Ital Med Int; 2001; 16(4):220-32. PubMed ID: 11799630
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ABT-874, a fully human monoclonal anti-IL-12/IL-23 antibody for the potential treatment of autoimmune diseases.
    Ding C; Xu J; Li J
    Curr Opin Investig Drugs; 2008 May; 9(5):515-22. PubMed ID: 18465662
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MIF in autoimmunity and novel therapeutic approaches.
    Stosic-Grujicic S; Stojanovic I; Nicoletti F
    Autoimmun Rev; 2009 Jan; 8(3):244-9. PubMed ID: 18721909
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Immunomodulation therapy for autoimmune diseases. New hope for patients with autoimmune diseases].
    Szegedi G
    Orv Hetil; 2005 Apr; 146(14):635-43. PubMed ID: 15889537
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fontolizumab Protein Design Labs.
    Dumont FJ
    Curr Opin Investig Drugs; 2005 May; 6(5):537-44. PubMed ID: 15912969
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Emerging applications of anticytokine vaccines.
    Delavallée L; Assier E; Semerano L; Bessis N; Boissier MC
    Expert Rev Vaccines; 2008 Dec; 7(10):1507-17. PubMed ID: 19053207
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Drug targets in the cytokine universe for autoimmune disease.
    Liu X; Fang L; Guo TB; Mei H; Zhang JZ
    Trends Immunol; 2013 Mar; 34(3):120-8. PubMed ID: 23116550
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modern anti-cytokine therapy of autoimmune diseases.
    Astrakhantseva IV; Efimov GA; Drutskaya MS; Kruglov AA; Nedospasov SA
    Biochemistry (Mosc); 2014 Dec; 79(12):1308-21. PubMed ID: 25716724
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cytokine inhibitors in rheumatoid arthritis and other autoimmune diseases.
    Williams RO; Paleolog E; Feldmann M
    Curr Opin Pharmacol; 2007 Aug; 7(4):412-7. PubMed ID: 17627887
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The therapeutic potential of anti-CD20 "what do B-cells do?".
    Eisenberg R; Looney RJ
    Clin Immunol; 2005 Dec; 117(3):207-13. PubMed ID: 16169773
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Agents against cytokine synthesis or receptors.
    Yamagata T; Ichinose M
    Eur J Pharmacol; 2006 Mar; 533(1-3):289-301. PubMed ID: 16457805
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Biological response modifiers in the treatment of immunoinflammatory diseases].
    Skov L; Bendtzen K
    Ugeskr Laeger; 2008 Jun; 170(24):2120-6. PubMed ID: 18565292
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.